You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glioblastoma, thrombocytopenia, temozolomide, chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

Terminated
Has Results
  • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
  • Chemotherapy with Temodar.
  • Radiation therapy
  • Baltimore, Maryland
    Ummc Msgcc
Dec 1, 2022

Recurrent or Progressive Glioblastoma Trial in Detroit (Bevacizumab, Bevacizumab with chemo, Fractionated radiosurgery)

Completed
  • Recurrent or Progressive Glioblastoma
  • Detroit, Michigan
    Henry Ford Health System
Jan 30, 2023

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Glioblastoma Trial in Milwaukee (Radiation, Concurrent Chemotherapy (Temozolomide), Adjuvant Chemotherapy (Temozolomide))

Recruiting
  • Glioblastoma
  • Radiation
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Jul 25, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

Brain Tumor Adult Trial in Birmingham (DRI cell therapy)

Recruiting
  • Brain Tumor Adult
  • DRI cell therapy
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 1, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Glioblastoma, Adult Trial in France (Radiotherapy)

Recruiting
  • Glioblastoma, Adult
  • Radiotherapy
  • Amiens, France
  • +6 more
Mar 31, 2022

Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

Recruiting
  • Glioblastoma
  • +3 more
  • Augusta, Georgia
  • +2 more
Aug 18, 2022

Glioblastoma Trial in Korea, Republic of (Temozolomide+Metformin, Temozolomide+Placebo)

Completed
  • Glioblastoma
  • Ilsan, Gyeonggi-Do, Korea, Republic of
  • +11 more
Sep 8, 2021

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Glioblastoma Trial (Iodine-125+Chemotherapy, Surgical resection+Radiochemo)

Not yet recruiting
  • Glioblastoma
  • Iodine-125+Chemotherapy
  • Surgical resection+Radiochemotherapy
  • (no location specified)
Jun 28, 2021

Glioblastoma Multiforme Trial in United States (Bevacizumab and Temozolomide)

Completed
Has Results
  • Glioblastoma Multiforme
  • Bevacizumab and Temozolomide
  • Chicago, Illinois
  • +4 more
Mar 5, 2021

Glioblastoma Multiforme of Brain Trial in Edegem (Dendritic cell vaccine plus temozolomide chemo)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Dendritic cell vaccine plus temozolomide chemotherapy
  • Edegem, Antwerp, Belgium
    Antwerp University Hospital
Jan 15, 2021

Glioblastoma (GBM) Trial in Phoenix (dietary supplement, radiation, drug)

Terminated
  • Glioblastoma (GBM)
  • Ketogenic Diet
  • +2 more
  • Phoenix, Arizona
    Barrow Neurological Institute at St. Joseph's Hospital and Medic
Jun 11, 2021

Glioblastoma Trial in Taipei City (CCRT, Temozolomide, Siroquine)

Recruiting
  • Glioblastoma
  • CCRT
  • +2 more
  • Taipei City, Taiwan
  • +1 more
May 10, 2021

Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Rochester (radiation, other, biological, drug, procedure)

Recruiting
  • Glioblastoma
  • +2 more
  • External Beam Radiation Therapy
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 4, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Glioma, Glioblastoma Trial in Norway, Sweden (Disulfiram, Copper, Alkylating Agents)

Completed
  • Glioma
  • Glioblastoma
  • Trondheim, Norway
  • +7 more
Mar 16, 2021

Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified

Not yet recruiting
  • Glioblastoma
  • Autologous genetically modified gamma-delta T cells
  • Allogeneic genetically modified gamma-delta T cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

Recruiting
  • Glioblastoma
  • Pembrolizumab and Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Ctr.
Jan 18, 2023